ArticleNeural regeneration research2024

Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration.

Rafael Simó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.